Drug Shortage Report for AVALIDE

Last updated on 2020-01-24 History
Report ID 89482
Drug Identification Number 02241819
Brand name AVALIDE
Common or Proper name Avalide
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 12.5MG 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-10-02
Estimated end date Unknown
Actual end date 2020-01-23
Shortage status Resolved
Updated date 2020-01-24
Company comments Increase in demand, supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2020-01-24 English Compare
v13 2020-01-23 French Compare
v12 2020-01-23 English Compare
v11 2019-11-05 French Compare
v10 2019-11-05 English Compare
v9 2019-10-09 French Compare
v8 2019-10-09 English Compare
v7 2019-10-09 French Compare
v6 2019-10-09 English Compare
v5 2019-10-02 French Compare
v4 2019-10-02 English Compare
v3 2019-08-16 English Compare
v2 2019-07-16 French Compare
v1 2019-07-16 English Compare